Prognosis of acute respiratory distress syndrome in neutropenic cancer patients

European Respiratory Journal

Volumn 40, Issue 1, 2012, Pages 169-176

  Mokart, Djamel ^a   Van Craenenbroeck, Thomas ^a   Lambert, Jérôme ^b   Textoris, Julien ^a   Brun, Jean Paul ^a   Sannini, Antoine ^a   Chow Chine, Laurent ^a   Hamouda, Smail ^a   Fouché, Louis ^a   Ettori, Florence ^a   Faucher, Marion ^a   Blache, Jean Louis ^a  

^a INSTITUT PAOLI CALMETTES   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

Acute respiratory distress syndrome; Cancer; Neutropenia; Prognosis

Indexed keywords

ADRENALIN; AMINOGLYCOSIDE; ANTIVIRUS AGENT; BETA LACTAM; CEFTAZIDIME; CILASTATIN; COLISTIN; CORTICOSTEROID; COTRIMOXAZOLE; DOBUTAMINE; HYPERTENSIVE FACTOR; IMIPENEM; NEUROMUSCULAR BLOCKING AGENT; NORADRENALIN; QUINOLONE DERIVATIVE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TICARCILLIN; VANCOMYCIN;

ACUTE LEUKEMIA; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; DISEASE ASSOCIATION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; FRANCE; HUMAN; INTENSIVE CARE UNIT; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELOMA; NEUTROPENIA; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; SOLID TUMOR; STENOTROPHOMONAS MALTOPHILIA;

ADULT; AGED; ANTI-BACTERIAL AGENTS; FEMALE; FRANCE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; NEOPLASMS; NEUTROPENIA; PROGNOSIS; PROSPECTIVE STUDIES; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK FACTORS;

EID: 84863452203     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00150611     Document Type: Article

References (30)

1. Brenner H, Gondos A, Arndt V. Recent major progress in long-term cancer patient survival disclosed by modeled period analysis. J Clin Oncol 2007; 25: 3274-3280. (Pubitemid 47325612)
2. Talpaz M, Shah NP, Kantarjian H, et al. Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias. N Engl J Med 2006; 354: 2531-2541. (Pubitemid 43882349)
3. Rossini F, Verga M, Pioltelli P, et al. Incidence and outcome of pneumonia in patients with acute leukemia receiving first induction therapy with anthracycline-containing regimens. Haematologica 2000; 85: 1255-1260. (Pubitemid 32063694)
4. Puig N, De La Rubia J, Jarque I, et al. Characteristics of and risk factors for pneumonia in patients with hematological malignancies developing fever after autologous blood stem cell transplantation. Leuk Lymphoma 2007; 48: 2367-2374. (Pubitemid 350258302)
5. Ognibene FP, Martin SE, Parker MM, et al. Adult respiratory distress syndrome in patients with severe neutropenia. N Engl J Med 1986; 315: 547-551. (Pubitemid 16052467)
6. Azoulay E, Schlemmer B. Diagnostic strategy in cancer patients with acute respiratory failure. Intensive Care Med 2006; 32: 808-822. (Pubitemid 43781361)
7. Azoulay E, Mokart D, Rabbat A, et al. Diagnostic bronchoscopy in hematology and oncology patients with acute respiratory failure: prospective multicenter data. Crit Care Med 2008; 36: 100-107.
8. Bernard GR, Artigas A, Brigham KL, et al. The American- European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-824. (Pubitemid 24082248)
9. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-874.
10. Puybasset L, Cluzel P, Gusman P, et al. Regional distribution of gas and tissue in acute respiratory distress syndrome. I. Consequences for lung morphology. CT Scan ARDS Study Group. Intensive Care Med 2000; 26: 857-869. (Pubitemid 30616038)
11. Agarwal R, Srinivas R, Nath A, et al. Is the mortality higher in the pulmonary vs the extrapulmonary ARDS? A meta analysis. Chest 2008; 133: 1463-1473. (Pubitemid 351893004)
12. Heussel CP, Kauczor HU, Heussel GE, et al. Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: use of high-resolution computed tomography. J Clin Oncol 1999; 17: 796-805. (Pubitemid 29109308)
13. Hughes WT, Armstrong D, Bodey GP, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34: 730-751. (Pubitemid 34194843)
14. Mokart D, Sannini A, Brun JP, et al. Oncohematology patients with febrile neutropenia hospitalized in ICU: clinical practice guidelines. Réanimation 2008; 17: 213-224.
15. Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004; 30: 536-555. (Pubitemid 38541501)
16. Brower RG, Lanken PN, MacIntyre N, et al. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004; 351: 327-336.
17. Rubin DB, Schenker N. Multiple imputation in health-care databases: an overview and some applications. Stat Med 1991;10: 585-598.
18. Benoit DD, Vandewoude KH, Decruyenaere JM, et al. Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication. Crit Care Med 2003; 31: 104-112. (Pubitemid 36151158)
19. Vandijck DM, Benoit DD, Depuydt PO, et al. Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignancies. Intensive Care Med 2008; 34: 847-855.
20. Rouby JJ, Puybasset L, Cluzel P, et al. Regional distribution of gas and tissue in acute respiratory distress syndrome. II. Physiological correlations and definition of an ARDS Severity Score. CT Scan ARDS Study Group. Intensive Care Med 2000; 26: 1046-1056.
21. Navigante AH, Cerchietti LC, Costantini P, et al. Conventional chest radiography in the initial assessment of adult cancer patients with fever and neutropenia. Cancer Control 2002; 9: 346-351. (Pubitemid 34921040)
22. Lin MY, Weinstein RA, Hota B. Delay of active antimicrobial therapy and mortality among patients with bacteremia: impact of severe neutropenia. Antimicrob Agents Chemother 2008; 52:3188-3194.
23. Safdar A, Rolston KV. Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer. Clin Infect Dis 2007; 45: 1602-1609. (Pubitemid 351411846)
24. Trecarichi EM, Tumbarello M, Spanu T, et al. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. J Infect 2009; 58: 299-307.
25. Kasiakou SK, Michalopoulos A, Soteriades ES, et al. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Antimicrob Agents Chemother 2005; 49:3136-3146. (Pubitemid 41060551)
26. Blot S, Depuydt P, Vogelaers D, et al. Colonization status and appropriate antibiotic therapy for nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in an intensive care unit. Infect Control Hosp Epidemiol 2005; 26: 575-579. (Pubitemid 40896148)
27. Depuydt P, Benoit D, Vogelaers D, et al. Outcome in bacteremia associated with nosocomial pneumonia and the impact of pathogen prediction by tracheal surveillance cultures. Intensive Care Med 2006; 32: 1773-1781. (Pubitemid 44607365)
28. Mokart D, Guery BP, Bouabdallah R, et al. Deactivation of alveolar macrophages in septic neutropenic ARDS. Chest 2003; 124:644-652. (Pubitemid 37000146)
29. Wheeler AP, Bernard GR. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet 2007; 369:1553-1564. (Pubitemid 46670280)
30. Lecuyer L, Chevret S, Thiery G, et al. The ICU trial: a new admission policy for cancer patients requiring mechanical ventilation. Crit Care Med 2007; 35: 808-814. (Pubitemid 46407795)